Victory Capital Management
KERX

Victory Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Victory Capital Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,619
Closed -$14K – 1850
2016
Q3 		$14K Buy
2,619
+176
+7% +$949 ﹤0.01% 1768
2016
Q2 		$16K Buy
2,443
+51
+2% +$285 ﹤0.01% 1607
2016
Q1 		$11K Buy
2,392
+187
+8% +$746 ﹤0.01% 1649
2015
Q4 		$11K Buy
2,205
+122
+6% +$580 ﹤0.01% 1667
2015
Q3 		$7K Sell
2,083
-1,006
-33% -$6.74K ﹤0.01% 1611
2015
Q2 		$31K Sell
3,089
-14,661
-83% -$157K ﹤0.01% 1571
2015
Q1 		$226K Sell
17,750
-401,825
-96% -$5.17M ﹤0.01% 771
2014
Q4 		$5.94M Buy
+419,575
New +$6.5M 0.02% 528

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Victory Capital Management's KERX Position: Q4 2016 in Review

Victory Capital Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2016, closing a stake of 2,619 shares — an estimated $14K sold.

Victory Capital Management first reported a position in KERX in Q4 2014 and held it in 8 quarters. The position peaked at $5.94M in Q4 2014. 123 funds tracked by Wall St. Rank hold KERX as of Q4 2016.

  • Victory Capital Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
  • Victory Capital Management sold 2,619 Keryx Biopharmaceuticals Inc shares in Q4 2016, an estimated $14K.
  • Victory Capital Management first reported a position in Keryx Biopharmaceuticals Inc in Q4 2014 and held it in 8 quarters.
  • Victory Capital Management's Keryx Biopharmaceuticals Inc position peaked at $5.94M in Q4 2014.
  • 123 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2016.

Based on Victory Capital Management's 13F filing for Q4 2016, filed 9 Feb 2017.